Therapy Areas: Diabetes
16 November 2018 - - US-based pharmaceutical company KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) has provided an update on the hereditary angioedema candidate KVD900, the company said.

...
15 November 2018 - - Anglo-Swedish pharmaceutical company AstraZeneca (OTC: AZNCF) has received positive full results from the DECLARE-TIMI 58 cardiovascular outcomes trial for Farxiga (dapagliflozin)...
15 November 2018 - - French research and development company Valbiotis has expanded the application for Valedia to NASH2prevention, the company said.

This new field of application is base...
12 November 2018 - - US-based biotechnology company PharmaCyte Biotech, Inc. (OTCQB: PMCB) has selected contract research organisation Medpace, Inc. to conduct PharmaCyte's clinical trial in...
12 November 2018 - Visterra, a clinical stage biotechnology firm, has commenced a phase one clinical study of VIS649 in healthy volunteers, it was reported on Friday.The product is a monoclonal antibo...
8 November 2018 - - US-based preclinical stage company Scioto Biosciences has presented data showing significant reduction of incidence and severity of experimental Clostridium difficile infection and...
Related Headlines